Last updated: June 1, 2022, 3:30 p.m.
Data collected from Mylan | No info available about the board members and financial figures

Mylan is a global pharmaceutical company committed to setting new standards in healthcare and providing the world’s 7 billion people access to high quality medicine. We offer a growing portfolio of more than 7,500 products including prescription generic, branded generic, brand-name drugs and over-the-counter remedies. We market our products in more than 165 countries and territories. Every member of our approximately 35,000-strong workforce is dedicated to creating better health for a better world.

Our mission is grounded in the belief that every person matters and should have the opportunity to live the healthiest life possible. We've built our business model consistent with this belief. Through it, we are impacting people around the world with each passing year.

Providing universal access to medicine is the core purpose of our model, pictured below.

To provide access, we must be able to satisfy the needs of an incredibly diversified global marketplace whose economic and political systems, approaches to delivering and paying for healthcare, languages and traditions, and customer and patient requirements vary by location and over time.

Player Type
Qualified Investors
Main Listed Market
Free Float
%
Number of assets
0
Legal Domicile
USA

ADD INFO TO THIS COMPANY

The information contained in the deals are public and based on best efforts to collect accurate information.

As a subscriber please help us to improve our data, reporting any error or adding details.

If your company participated in this deal, please let us know and describe the role of your company in this deal.

All the “Messages” sent will be public to all other users, identifying thru your subscription details who published each “Message”.

All “Messages” are subjected to a revision process before public release in the platform, so your “Message” will not be immediately released.

If you have any problems or need help, please contact us –data@iberian.property Thanks.

SENT MESSAGES >>